Redmile Group LLC Trims Stock Position in Stereotaxis, Inc. (NYSEAMERICAN:STXS)

Redmile Group LLC decreased its holdings in Stereotaxis, Inc. (NYSEAMERICAN:STXS) by 14.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,799,465 shares of the company’s stock after selling 308,754 shares during the quarter. Redmile Group LLC owned 2.12% of Stereotaxis worth $4,103,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. ProShare Advisors LLC increased its stake in shares of Stereotaxis by 53.6% in the fourth quarter. ProShare Advisors LLC now owns 15,913 shares of the company’s stock worth $36,000 after purchasing an additional 5,556 shares in the last quarter. Two Sigma Securities LLC purchased a new stake in Stereotaxis in the 4th quarter worth $54,000. SG Americas Securities LLC raised its holdings in Stereotaxis by 39.2% during the fourth quarter. SG Americas Securities LLC now owns 26,360 shares of the company’s stock valued at $60,000 after acquiring an additional 7,417 shares during the period. Wells Fargo & Company MN lifted its position in shares of Stereotaxis by 53.7% in the fourth quarter. Wells Fargo & Company MN now owns 26,915 shares of the company’s stock valued at $61,000 after acquiring an additional 9,403 shares in the last quarter. Finally, Jane Street Group LLC boosted its stake in shares of Stereotaxis by 26.9% in the third quarter. Jane Street Group LLC now owns 29,773 shares of the company’s stock worth $61,000 after acquiring an additional 6,313 shares during the period. 45.35% of the stock is currently owned by institutional investors.

Insider Activity

In related news, Director Paul J. Isaac acquired 38,000 shares of the stock in a transaction dated Monday, March 10th. The stock was acquired at an average cost of $1.81 per share, with a total value of $68,780.00. Following the purchase, the director now directly owns 87,299 shares of the company’s stock, valued at approximately $158,011.19. This trade represents a 77.08% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Company insiders own 18.52% of the company’s stock.

Stereotaxis Trading Down 3.3%

Shares of STXS opened at $2.04 on Thursday. The business’s 50 day moving average is $1.88 and its 200 day moving average is $2.07. Stereotaxis, Inc. has a 12-month low of $1.54 and a 12-month high of $2.72. The company has a market capitalization of $172.85 million, a PE ratio of -7.29 and a beta of 1.54.

Stereotaxis Profile

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.